email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
376 - 390
of 3615 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
Ractigen Starts China Trials of siRNA Candidate for ALS Patients
$5.00
Available
HighTide Plans Hong Kong IPO to Support Metabolic and Digestive Portfolio
$5.00
Available
WestVac Biopharma Approved to Launch COVID-19 Vaccine for XBB Variants
$5.00
Available
Fosun Pharma Lands $107 Million to Build African Production and Distribution Facility
$5.00
Available
Innovent/IASO Release Strong Long-Term Data on CAR-T for Multiple Myeloma
$5.00
Available
iTabMed Approved to Start China Trials of CD3 Bi-specific for Solid Tumors
$5.00
Available
Dizal Updates Clinical News of its Two Global Trial Assets at ASCO
$5.00
Available
ASCO: BioNTech and Merck Present Positive Data on China-Sourced Oncology Drugs
$5.00
Available
Gracell Reports Positive Data from Trial of BCMA/CD19 FasTCAR-T in Multiple Myeloma
$5.00
Available
CANbridge Approved to Launch Pruritus Therapy for Alagille Syndrome in China
$5.00
Available
Connect Reports UC Therapy Offers Statistically Significant Improvement
$5.00
Available
invoX Makes 2nd Investment in pHion, a Belfast mRNA Vaccine Company
$5.00
Available
Lynk Pharma Closes C1 Round with $28 Million for Oncology and Autoimmune Drugs
$5.00
Available
HighField Biopharma Reports Progression-Free Survival in Glioma Patients
$5.00
Available
Betta Signs $392 Million Agreement for Lung Cancer Drug with C4 Therapeutics
$5.00
Available